Dr. Marijn van Os

CEO at Scinvivo BV
van Os, Marijn
SPIE Leadership: Retrieving Data, please wait...
SPIE Membership: 1.0 years
SPIE Involvement: Retrieving Data, please wait...
Websites: Company Website
Social Media: LinkedIn | LinkedIn
Contact Details:
Sign In to send a private message or view contact details

Profile Summary

Marijn van Os is CEO at Scinvivo, since October 2019 and co-founder of Scinvivo. As an entrepreneur he also founded Innoluce in 2010 as a spin-off of Royal Philips, including acquiring the main MEMS mirror IPR. Marijn successfully managed the acquisition of Innoluce by Infineon in 2016 for the automotive applications. Prior to this acquisition the medical assets, IPR and knowhow was transferred to Scinvivo. Marijn holds a PhD in mechanical engineering and continued his working career at Philips where he held different positions as technologist and development manager within The Netherlands and in the Czech Republic. Marijn has an extensive international network in the MEMS space and in the medical space for urology. Marijn always looks for opportunities to sell. In his days at Philips he was responsible for 4€m/year turnover and in his days at Innoluce he raised money via NRE deals and selling of LIDAR demonstrators. As serial entrepreneur Marijn has closed different investment rounds and has built a nice trusted network of investors.
Marijn is always looking for opportunities to improve and challenge the status quo and as such he is convinced that with the solution of Scinvivo the unmet needs in the cancer diagnostics & care will be improved significantly for all stakeholders, but in particular for the patients.

Upcoming Presentations

Most Recent | Show All
Retrieving Data, please wait...

Publications

Most Recent | Show All
Retrieving Data, please wait...

Conference Committee Involvement

Most Recent | Show All
Retrieving Data, please wait...

Course Instructor

Most Recent | Show All
Retrieving Data, please wait...
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research